HSBC Holdings
FBRX icon

HSBC Holdings’s Forte Biosciences FBRX Stock Holding History

HSBC Holdings’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-430
Closed -$5.89K – 3032
2024
Q2 		$5.89K Hold
430
– – ﹤0.01% 2905
2024
Q1 		$7.53K Hold
430
– – ﹤0.01% 3022
2023
Q4 		$8.7K Hold
430
– – ﹤0.01% 2695
2023
Q3 		$6.97K Hold
430
– – ﹤0.01% 2690
2023
Q2 		$10.9K Hold
430
– – ﹤0.01% 2533
2023
Q1 		$10.6K Hold
430
– – ﹤0.01% 2621
2022
Q4 		$10.5K Sell
430
-46
-10% -$1.18K ﹤0.01% 3030
2022
Q3 		$13K Sell
476
-35
-7% -$1.11K ﹤0.01% 2883
2022
Q2 		$17K Buy
511
+1
+0.2% +$32 ﹤0.01% 3199
2022
Q1 		$19K Hold
510
– – ﹤0.01% 3234
2021
Q4 		$28K Buy
+510
New +$34.3K ﹤0.01% 3224

Other funds holding FBRX

TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HSBC Holdings's FBRX Position: Q3 2024 in Review

HSBC Holdings sold out of Forte Biosciences (FBRX) in Q3 2024, closing a stake of 430 shares — an estimated $5.89K sold.

HSBC Holdings first reported a position in FBRX in Q4 2021 and held it in 11 quarters. The position peaked at $28K in Q4 2021. 24 funds tracked by Wall St. Rank hold FBRX as of Q3 2024.

  • HSBC Holdings reported no remaining Forte Biosciences position as of Q3 2024 after selling out during the quarter.
  • HSBC Holdings sold 430 Forte Biosciences shares in Q3 2024, an estimated $5.89K.
  • HSBC Holdings first reported a position in Forte Biosciences in Q4 2021 and held it in 11 quarters.
  • HSBC Holdings's Forte Biosciences position peaked at $28K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2024.

Based on HSBC Holdings's 13F filing for Q3 2024, filed 14 Nov 2024.